Skip to main content
UNION KOREA PHARM CO.,Ltd logo

UNION KOREA PHARM CO.,Ltd — Investor Relations & Filings

Ticker · 080720 ISIN · KR7080720006 KO Manufacturing
Open in API
Filings indexed 429 across all filing types
Latest filing 2026-02-05 Regulatory Filings
Country KR South Korea
Listing KO 080720

About UNION KOREA PHARM CO.,Ltd

https://ukp.co.kr/

UNION KOREA PHARM CO.,Ltd. is a pharmaceutical company engaged in the research, development, manufacturing, and distribution of prescription drugs. The company produces a range of specialty medicines in various formulations, including solid dosage forms, liquid injections, and powders. Its product portfolio addresses therapeutic areas such as neoplasms, immune system diseases, anti-inflammatory analgesics, antibiotics, and skeletal muscle relaxants. The company emphasizes strict quality control throughout the entire production cycle, from raw materials to shipping, to ensure its products meet Good Manufacturing Practice (GMP) standards. It operates in both domestic and international markets.

Recent filings

Filing Released Lang Actions
[기재정정]회생절차개시결정
Regulatory Filings Classification · 95% confidence The document is a regulatory filing from the Korea Exchange (KRX) regarding a 'Rehabilitation Procedure Commencement Decision' (회생절차개시결정) for Korea Union Pharmaceutical. It details a correction (amendment) to a previous filing concerning the extension of the deadline for submitting a rehabilitation plan. Since this document pertains to legal proceedings and court-ordered rehabilitation, it falls under the category of legal matters/regulatory actions. Given the specific nature of the filing, 'LTR' (Legal Proceedings Report) is the most appropriate classification.
2026-02-05 Korean
[기재정정]회생절차개시결정
Legal Proceedings Report Classification · 95% confidence The document is a regulatory filing from the Korea Exchange (KRX) regarding a 'Rehabilitation Procedure Commencement Decision' (회생절차개시결정) for Korea Union Pharmaceutical. It specifically details a correction (정정신고) to a previous filing, updating the deadline for the submission of the rehabilitation plan. Since this relates to legal/regulatory proceedings regarding the company's insolvency and restructuring, and does not fit into specific categories like M&A or financial reports, it is classified as a Legal Proceedings Report (LTR).
2026-01-13 Korean
투자판단관련주요경영사항 (회생회사 한국유니온제약(주) 인수 M&A 최종 인수자 선정)
M&A Activity Classification · 100% confidence The document is an official regulatory filing from the Korea Exchange (KRX) regarding the selection of a final acquirer for a company undergoing rehabilitation (M&A). The content explicitly details the M&A process, the selection of the preferred bidder (Bukwang Pharmaceutical), and the terms of the investment agreement. This falls directly under M&A activity.
2026-01-05 Korean
기타경영사항(자율공시) (회생회사 한국유니온제약 주식회사 M&A 공고)
M&A Activity Classification · 100% confidence The document is an official announcement regarding the M&A process for a company currently under rehabilitation (회생회사). It details the sale method, bidding process, and specific timelines for submitting letters of intent and bids. This falls directly under M&A activity (TAR) as it pertains to the sale and takeover process of the company.
2025-12-19 Korean
기타경영사항(자율공시) (M&A 조건부 투자계약 체결)
M&A Activity Classification · 100% confidence The document is an official announcement regarding a 'Conditional Investment Agreement' for an M&A transaction involving Korea Union Pharm. It details the contract parties, the nature of the 'Stalking-Horse Bid' M&A process, and the legal context of the rehabilitation proceedings. Since this document specifically concerns a merger and acquisition proposal/agreement, it falls under the M&A Activity category.
2025-12-17 Korean
횡령ㆍ배임혐의진행사항
Legal Proceedings Report Classification · 95% confidence The document is a regulatory announcement regarding the progress of embezzlement and breach of trust allegations involving a former executive of the company. It provides details such as the amount involved, dates, and references to prior disclosures. The document is short (993 characters) and does not contain financial statements or detailed financial analysis. It is an update on legal proceedings rather than a full legal report or audit. Therefore, it fits best under Legal Proceedings Report (LTR).
2025-10-14 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.